581 related articles for article (PubMed ID: 9666154)
1. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMP levels in discrete rat brain regions and spinal cord.
Sheu MJ; Sribanditmongkol P; Santosa DN; Tejwani GA
Brain Res; 1995 Mar; 675(1-2):31-7. PubMed ID: 7796144
[TBL] [Abstract][Full Text] [Related]
3. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
Reddy PL; Veeranna ; Matwyshyn GA; Thorat SN; Bhargava HN
Gen Pharmacol; 1994 Mar; 25(2):355-61. PubMed ID: 8026736
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of morphine tolerance and dependence by diazepam and its relation to the CNS Met-enkephalin levels.
Sribanditmongkol P; Sheu MJ; Tejwani GA
Brain Res; 1994 May; 645(1-2):1-12. PubMed ID: 8062072
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
Bhargava HN; Gulati A
Eur J Pharmacol; 1990 Nov; 190(3):305-11. PubMed ID: 2176984
[TBL] [Abstract][Full Text] [Related]
6. Effects of naltrexone on the binding of [3H]D-Ala2, MePhe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat.
Bhargava HN; Matwyshyn GA; Reddy PL; Veeranna
Gen Pharmacol; 1993 Nov; 24(6):1351-7. PubMed ID: 8112506
[TBL] [Abstract][Full Text] [Related]
7. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
Aley KO; Levine JD
J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
[TBL] [Abstract][Full Text] [Related]
8. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice.
Abdelhamid EE; Takemori AE
Eur J Pharmacol; 1991 Jun; 198(2-3):157-63. PubMed ID: 1650700
[TBL] [Abstract][Full Text] [Related]
10. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
Yoburn BC; Purohit V; Patel K; Zhang Q
Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
[TBL] [Abstract][Full Text] [Related]
11. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
12. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
13. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury.
Porreca F; Tang QB; Bian D; Riedl M; Elde R; Lai J
Brain Res; 1998 Jun; 795(1-2):197-203. PubMed ID: 9622629
[TBL] [Abstract][Full Text] [Related]
14. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
15. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
Alcaraz C; Vargas ML; Milanés MV
Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
[TBL] [Abstract][Full Text] [Related]
16. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
[TBL] [Abstract][Full Text] [Related]
17. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
Mellon RD; Bayer BM
Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
[TBL] [Abstract][Full Text] [Related]
18. Effects of prenatal morphine and adult estrogen administration on mu-opioid inhibition of norepinephrine release from hypothalamic slices.
Vathy I; Etgen AM
Neuroendocrinology; 1996 Jan; 63(1):61-8. PubMed ID: 8839356
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.
Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR
Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823
[TBL] [Abstract][Full Text] [Related]
20. Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density.
Chan KW; Duttory A; Yoburn BC
Eur J Pharmacol; 1997 Jan; 319(2-3):225-8. PubMed ID: 9042594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
